Framing expectations in early HIV cure research

Horwitz, 1964, Nucleosides. V. The monomesylates of 1-(2′-deoxy-beta-Dlyxofuranosyl)thymidine, J. Org. Chem., 29, 2076, 10.1021/jo01030a546 Advisory Committee on Human Radiation Experiments, 1995 Prins, 1999, Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1 infected patients on potent antiretroviral therapy, AIDS, 13, 2405, 10.1097/00002030-199912030-00012 Gordin, 2006, CD4+ count-guided interruption of antiretroviral treatment, N. Engl. J. Med., 355, 2283, 10.1056/NEJMoa062360 Allers, 2011, Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation, Blood, 117, 2791, 10.1182/blood-2010-09-309591 Persaud, 2013, Absence of detectable HIV-1 viremia after treatment cessation in an infant, N. Engl. J. Med., 369, 1828, 10.1056/NEJMoa1302976 Lehrman, 2005, Depletion of latent HIV-1 infection in vivo: a proof-of-concept study, Lancet, 366, 549, 10.1016/S0140-6736(05)67098-5 Archin, 2009, Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid, AIDS Res. Hum. Retroviruses, 25, 207, 10.1089/aid.2008.0191 Archin, 2014, HIV-1 expression within resting CD4+ T cells after multiple doses of vorinostat, J. Infect. Dis., 10.1093/infdis/jiu155 Saglio, 2014, The time is now: moving toward virus-specific T cells after allogeneic hematopoietic stem cell transplantation as the standard of care, Cytotherapy, 16, 149, 10.1016/j.jcyt.2013.11.010 Appelbaum, 1982, The therapeutic misconception: informed consent in psychiatric research, Int. J. Law Psychiatry, 5, 319, 10.1016/0160-2527(82)90026-7 Henderson, 2007, Clinical trials and medical care: defining the therapeutic misconception, PLoS Med., 4, 1735, 10.1371/journal.pmed.0040324